A PYMNTS Company

US: FTC seeks more information on Pfizer-Allergan merger

By  |  March 30, 2016

Pfizer and Allergan said they have received a request for additional information from the US Federal Trade Commission with respect to their merger.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    Subscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The FTC’s request for information extends the waiting period required under antitrust rules to 30 days, after the companies have provided the information.

    The companies said the request was anticipated as part of the regulatory process and they were working with the FTC in connection with the review.

    The companies continue to expect the deal to close in the second half of 2016.

    Full content: The Japan Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.